<DOC>
	<DOCNO>NCT01675973</DOCNO>
	<brief_summary>The purpose study assess effect severe renal impairment steady-state PK , well safety tolerability , ranolazine , compare subject normal renal function .</brief_summary>
	<brief_title>A Phase 1 Study Assess Effect Severe Renal Impairment Pharmacokinetics , Well Safety/Tolerability , Ranolazine</brief_title>
	<detailed_description>The primary objective study assess effect severe renal impairment ( RI ) steady-state pharmacokinetics ( PK ) ranolazine key metabolite . The secondary objective study assess safety tolerability multiple oral dos ranolazine subject severe RI .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Ranolazine</mesh_term>
	<criteria>Inclusion criterion ( All Cohorts ) : Males female , 18 75 year old , inclusive Body mass index ( BMI ) 18 40 kg/m2 , inclusive , Screening Females childbearing potential must negative pregnancy test Screening Day 1 ( Cohort A ) Day 6 ( Cohort B ) must agree use highly effective contraception method Screening throughout duration Treatment Period 14 day follow last dose study drug Inclusion criterion ( Cohort A [ Healthy subject normal renal function ] ) : Estimated creatinine clearance ( CLCR ) , accord CockcroftGault ( CG ) equation , â‰¥ 90 mL/min Screening Age , BMI , sex comparable subject Cohort B Good health status determine clinically significant deviation normal medical history , physical examination , ECGs , clinical laboratory determination Inclusion criterion ( Cohort B , Severe RI ) : Diagnosis CKD Estimated glomerular filtration rate ( eGFR ) , accord Modification Diet Renal Disease ( MDRD ) equation , &lt; 30 mL/min/1.73 m2 ( receive dialysis ) Stable medication dose dose regimen treatment complication renal disease concomitant chronic illness least 2 week prior study drug administration Exclusion criterion ( All Cohorts ) : History uncontrolled unstable cardiovascular , respiratory , hepatic , gastrointestinal , endocrine , hematopoietic , psychiatric , and/or neurological disease Current recent ( within 3 month ) gastrointestinal ( GI ) disease GI surgery could impact absorption study drug Any major surgery within 4 week dose study drug Donation blood plasma blood bank clinical study ( except screen visit ) within 4 week dose study drug Blood transfusion within 4 week dose study drug Consumption &gt; 14 alcoholic drink per week , 4 alcoholic drink one day History regular use tobacco nicotinecontaining product excess 10 cigarette per day equivalent History substance abuse within 12 month prior Screening Positive drug screen Positive alcohol test Clinically significant history hepatic disease QTcF interval &gt; 480 msec Screening Day 6 ( Cohort B ) Day 1 ( Cohort A ) History unexplained syncope , cardiac arrest , unexplained cardiac arrhythmia , torsade de point Known hypersensitivity previous intolerance ranolazine excipients Treatment select medication Pregnancy lactation Other condition ( ) , opinion Investigator , would prevent compliance study protocol Exclusion criterion ( Cohort A [ Healthy subject normal renal function ] ) : Evidence organ dysfunction clinically significant deviation normal physical examination , vital sign , ECG , clinical laboratory determination Hemoglobin &lt; 12 g/dL male , &lt; 11 g/dL female Screening Any prescription overthecounter medication , include herbal product Exclusion criterion ( Cohort B , Severe RI ) : Any clinical , ECG , laboratory finding beyond consistent degree renal dysfunction History anticipate nearterm need renal transplant ( within 3 month ) History hemodialysis peritoneal dialysis within 1 year prior Screening , anticipate need hemodialysis peritoneal dialysis study History acute renal failure nephrotic syndrome within 1 year prior Screening History diabetic ketoacidosis History severe hypoglycemia Other condition ( ) , opinion Investigator , would prevent compliance study protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Ranolazine</keyword>
	<keyword>renal impairment</keyword>
</DOC>